{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:50:29Z","timestamp":1794336629791,"version":"4.9.0"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41581-022-00600-0","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T08:03:24Z","timestamp":1658995404000},"page":"663-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Activation and regulation of alloreactive T cell immunity in solid organ transplantation"],"prefix":"10.1038","volume":"18","author":[{"given":"Charlotte","family":"Duneton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela D.","family":"Winterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6736-4421","authenticated-orcid":false,"given":"Mandy L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"600_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1600-065X.1987.tb00523.x","volume":"98","author":"A Singer","year":"1987","unstructured":"Singer, A., Munitz, T. I., Golding, H., Rosenberg, A. S. & Mizuochi, T. Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens. Immunol. Rev. 98, 143\u2013170 (1987).","journal-title":"Immunol. Rev."},{"key":"600_CR2","first-page":"321","volume":"19","author":"EM Bolton","year":"1987","unstructured":"Bolton, E. M., Armstrong, H. E., Briggs, J. D. & Bradley, J. A. Cellular requirements for first-set renal allograft rejection. Transpl. Proc. 19, 321\u2013323 (1987).","journal-title":"Transpl. Proc."},{"key":"600_CR3","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1084\/jem.169.6.1931","volume":"169","author":"EM Bolton","year":"1989","unstructured":"Bolton, E. M., Gracie, J. A., Briggs, J. D., Kampinga, J. & Bradley, J. A. Cellular requirements for renal allograft rejection in the athymic nude rat. J. Exp. Med. 169, 1931\u20131946 (1989).","journal-title":"J. Exp. Med."},{"key":"600_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.136.2.389","volume":"136","author":"JD Ashwell","year":"1986","unstructured":"Ashwell, J. D., Chen, C. & Schwartz, R. H. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J. Immunol. 136, 389\u2013395 (1986).","journal-title":"J. Immunol."},{"key":"600_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4049\/jimmunol.166.2.973","volume":"166","author":"EJ Suchin","year":"2001","unstructured":"Suchin, E. J. et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166, 973\u2013981 (2001).","journal-title":"J. Immunol."},{"key":"600_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.iy.11.040193.002125","volume":"11","author":"LA Sherman","year":"1993","unstructured":"Sherman, L. A. & Chattopadhyay, S. The molecular basis of allorecognition. Annu. Rev. Immunol. 11, 385\u2013402 (1993).","journal-title":"Annu. Rev. Immunol."},{"key":"600_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1082167","volume":"191","author":"DW Talmage","year":"1976","unstructured":"Talmage, D. W., Dart, G., Radovich, J. & Lafferty, K. J. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 191, 385\u2013388 (1976).","journal-title":"Science"},{"key":"600_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1084\/jem.155.1.31","volume":"155","author":"RI Lechler","year":"1982","unstructured":"Lechler, R. I. & Batchelor, J. R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155, 31\u201341 (1982).","journal-title":"J. Exp. Med."},{"key":"600_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1172\/JCI10467","volume":"106","author":"BA Pietra","year":"2000","unstructured":"Pietra, B. A., Wiseman, A., Bolwerk, A., Rizeq, M. & Gill, R. G. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106, 1003\u20131010 (2000).","journal-title":"J. Clin. Invest."},{"key":"600_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.171.1.307","volume":"171","author":"CP Larsen","year":"1990","unstructured":"Larsen, C. P., Morris, P. J. & Austyn, J. M. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J. Exp. Med. 171, 307\u2013314 (1990).","journal-title":"J. Exp. Med."},{"key":"600_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00007890-198007000-00006","volume":"30","author":"S Oluwole","year":"1980","unstructured":"Oluwole, S. et al. Donor pretreatment: rat heart allograft survival and measurement of passenger leukocyte depletion with indium-111. Transplantation 30, 31\u201333 (1980).","journal-title":"Transplantation"},{"key":"600_CR12","first-page":"928759","volume":"2011","author":"HC Tai","year":"2011","unstructured":"Tai, H. C. et al. Attempted depletion of passenger leukocytes by irradiation in pigs. J. Transpl. 2011, 928759 (2011).","journal-title":"J. Transpl."},{"key":"600_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85293","volume":"1","author":"P Abrahimi","year":"2016","unstructured":"Abrahimi, P. et al. Blocking MHC class II on human endothelium mitigates acute rejection. JCI Insight 1, e85293 (2016).","journal-title":"JCI Insight"},{"key":"600_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00007890-199307000-00024","volume":"56","author":"CO Savage","year":"1993","unstructured":"Savage, C. O., Hughes, C. C., McIntyre, B. W., Picard, J. K. & Pober, J. S. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions. Transplantation 56, 128\u2013134 (1993).","journal-title":"Transplantation"},{"key":"600_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s004410050985","volume":"291","author":"V Grau","year":"1998","unstructured":"Grau, V., Herbst, B. & Steiniger, B. Dynamics of monocytes\/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res. 291, 117\u2013126 (1998).","journal-title":"Cell Tissue Res."},{"key":"600_CR16","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1046\/j.1523-1755.1999.00741.x","volume":"56","author":"JG Penfield","year":"1999","unstructured":"Penfield, J. G. et al. Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney. Kidney Int. 56, 1759\u20131769 (1999).","journal-title":"Kidney Int."},{"key":"600_CR17","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/00007890-200106270-00017","volume":"71","author":"T Saiki","year":"2001","unstructured":"Saiki, T., Ezaki, T., Ogawa, M. & Matsuno, K. Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 71, 1806\u20131815 (2001).","journal-title":"Transplantation"},{"key":"600_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nm.2376","volume":"17","author":"S Celli","year":"2011","unstructured":"Celli, S., Albert, M. L. & Bousso, P. Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy. Nat. Med. 17, 744\u2013749 (2011).","journal-title":"Nat. Med."},{"key":"600_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.175.1.305","volume":"175","author":"G Benichou","year":"1992","unstructured":"Benichou, G., Takizawa, P. A., Olson, C. A., McMillan, M. & Sercarz, E. E. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175, 305\u2013308 (1992).","journal-title":"J. Exp. Med."},{"key":"600_CR20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.4049\/jimmunol.153.3.938","volume":"153","author":"G Benichou","year":"1994","unstructured":"Benichou, G. et al. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation. J. Immunol. 153, 938\u2013945 (1994).","journal-title":"J. Immunol."},{"key":"600_CR21","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/00007890-199502270-00029","volume":"59","author":"L Gallon","year":"1995","unstructured":"Gallon, L. et al. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation 59, 612\u2013616 (1995).","journal-title":"Transplantation"},{"key":"600_CR22","first-page":"297","volume":"1","author":"PE Harris","year":"1999","unstructured":"Harris, P. E., Cortesini, R. & Suciu-Foca, N. Indirect allorecognition in solid organ transplantation. Rev. Immunogenet. 1, 297\u2013308 (1999).","journal-title":"Rev. Immunogenet."},{"key":"600_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0167-5699(98)01394-2","volume":"20","author":"DS Gould","year":"1999","unstructured":"Gould, D. S. & Auchincloss, H. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today 20, 77\u201382 (1999).","journal-title":"Immunol. Today"},{"key":"600_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/TP.0b013e31829853ce","volume":"96","author":"JM Ali","year":"2013","unstructured":"Ali, J. M., Bolton, E. M., Bradley, J. A. & Pettigrew, G. J. Allorecognition pathways in transplant rejection and tolerance. Transplantation 96, 681\u2013688 (2013).","journal-title":"Transplantation"},{"key":"600_CR25","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.4049\/jimmunol.167.12.7199","volume":"167","author":"RJ Baker","year":"2001","unstructured":"Baker, R. J. et al. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J. Immunol. 167, 7199\u20137206 (2001).","journal-title":"J. Immunol."},{"key":"600_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1600-6143.2011.03869.x","volume":"12","author":"LD Haynes","year":"2012","unstructured":"Haynes, L. D. et al. Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am. J. Transpl. 12, 640\u2013648 (2012).","journal-title":"Am. J. Transpl."},{"key":"600_CR27","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.celrep.2015.12.099","volume":"14","author":"JM Ali","year":"2016","unstructured":"Ali, J. M. et al. Diversity of the CD4 T cell alloresponse: the short and the long of it. Cell Rep. 14, 1232\u20131245 (2016).","journal-title":"Cell Rep."},{"key":"600_CR28","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.4049\/jimmunol.173.5.3027","volume":"173","author":"D Kreisel","year":"2004","unstructured":"Kreisel, D. et al. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J. Immunol. 173, 3027\u20133034 (2004).","journal-title":"J. Immunol."},{"key":"600_CR29","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1182\/blood-2002-11-3370","volume":"101","author":"H Hackstein","year":"2003","unstructured":"Hackstein, H. et al. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101, 4457\u20134463 (2003).","journal-title":"Blood"},{"key":"600_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1600-6143.2004.00673.x","volume":"5","author":"T Taner","year":"2005","unstructured":"Taner, T., Hackstein, H., Wang, Z., Morelli, A. E. & Thomson, A. W. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am. J. Transpl. 5, 228\u2013236 (2005).","journal-title":"Am. J. Transpl."},{"key":"600_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.trim.2011.05.001","volume":"25","author":"RT Fischer","year":"2011","unstructured":"Fischer, R. T., Turnquist, H. R., Wang, Z., Beer-Stolz, D. & Thomson, A. W. Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I\/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8+ T cells in vitro and in vivo. Transpl. Immunol. 25, 20\u201326 (2011).","journal-title":"Transpl. Immunol."},{"key":"600_CR32","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1172\/JCI84577","volume":"126","author":"Q Liu","year":"2016","unstructured":"Liu, Q. et al. Donor dendritic cell-derived exosomes promote allograft-targeting immune response. J. Clin. Invest. 126, 2805\u20132820 (2016).","journal-title":"J. Clin. Invest."},{"key":"600_CR33","doi-asserted-by":"publisher","first-page":"aaf8759","DOI":"10.1126\/sciimmunol.aaf8759","volume":"1","author":"J Marino","year":"2016","unstructured":"Marino, J. et al. Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation. Sci. Immunol. 1, aaf8759 (2016).","journal-title":"Sci. Immunol."},{"key":"600_CR34","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1182\/blood.V95.11.3473","volume":"95","author":"V Russo","year":"2000","unstructured":"Russo, V. et al. Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells. Blood 95, 3473\u20133477 (2000).","journal-title":"Blood"},{"key":"600_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/ni0903-815","volume":"4","author":"E Joly","year":"2003","unstructured":"Joly, E. & Hudrisier, D. What is trogocytosis and what is its purpose? Nat. Immunol. 4, 815 (2003).","journal-title":"Nat. Immunol."},{"key":"600_CR36","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1636::AID-IMMU1636>3.0.CO;2-9","volume":"28","author":"SC Knight","year":"1998","unstructured":"Knight, S. C., Iqball, S., Roberts, M. S., Macatonia, S. & Bedford, P. A. Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur. J. Immunol. 28, 1636\u20131644 (1998).","journal-title":"Eur. J. Immunol."},{"key":"600_CR37","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.161.3.1313","volume":"161","author":"M Wykes","year":"1998","unstructured":"Wykes, M., Pombo, A., Jenkins, C. & MacPherson, G. G. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161, 1313\u20131319 (1998).","journal-title":"J. Immunol."},{"key":"600_CR38","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.4049\/jimmunol.173.8.4828","volume":"173","author":"OB Herrera","year":"2004","unstructured":"Herrera, O. B. et al. A novel pathway of alloantigen presentation by dendritic cells. J. Immunol. 173, 4828\u20134837 (2004).","journal-title":"J. Immunol."},{"key":"600_CR39","doi-asserted-by":"publisher","first-page":"104063","DOI":"10.1016\/j.cellimm.2020.104063","volume":"349","author":"G Benichou","year":"2020","unstructured":"Benichou, G., Wang, M., Ahrens, K. & Madsen, J. C. Extracellular vesicles in allograft rejection and tolerance. Cell Immunol. 349, 104063 (2020).","journal-title":"Cell Immunol."},{"key":"600_CR40","doi-asserted-by":"publisher","first-page":"12788","DOI":"10.1073\/pnas.1513533112","volume":"112","author":"SJ Harper","year":"2015","unstructured":"Harper, S. J. et al. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection. Proc. Natl Acad. Sci. USA 112, 12788\u201312793 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"600_CR41","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1096\/fj.08-107441","volume":"22","author":"K Brown","year":"2008","unstructured":"Brown, K., Sacks, S. H. & Wong, W. Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation. FASEB J. 22, 3776\u20133784 (2008).","journal-title":"FASEB J."},{"key":"600_CR42","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1600-6143.2011.03437.x","volume":"11","author":"K Brown","year":"2011","unstructured":"Brown, K., Sacks, S. H. & Wong, W. Coexpression of donor peptide\/recipient MHC complex and intact donor MHC: evidence for a link between the direct and indirect pathways. Am. J. Transpl. 11, 826\u2013831 (2011).","journal-title":"Am. J. Transpl."},{"key":"600_CR43","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.4049\/jimmunol.1300458","volume":"190","author":"S Sivaganesh","year":"2013","unstructured":"Sivaganesh, S. et al. Copresentation of intact and processed MHC alloantigen by recipient dendritic cells enables delivery of linked help to alloreactive CD8 T cells by indirect-pathway CD4 T cells. J. Immunol. 190, 5829\u20135838 (2013).","journal-title":"J. Immunol."},{"key":"600_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/ajt.13996","volume":"17","author":"LA Smyth","year":"2017","unstructured":"Smyth, L. A., Lechler, R. I. & Lombardi, G. Continuous acquisition of MHC:peptide complexes by recipient cells contributes to the generation of anti-graft CD8+ T cell immunity. Am. J. Transpl. 17, 60\u201368 (2017).","journal-title":"Am. J. Transpl."},{"key":"600_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/molehr\/gah129","volume":"11","author":"L Fr\u00e4ngsmyr","year":"2005","unstructured":"Fr\u00e4ngsmyr, L. et al. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Hum. Reprod. 11, 35\u201341 (2005).","journal-title":"Mol. Hum. Reprod."},{"key":"600_CR46","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","volume":"109","author":"J LeMaoult","year":"2007","unstructured":"LeMaoult, J. et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 109, 2040\u20132048 (2007).","journal-title":"Blood"},{"key":"600_CR47","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood-2012-03-416792","volume":"120","author":"R Brown","year":"2012","unstructured":"Brown, R. et al. CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood 120, 2055\u20132063 (2012).","journal-title":"Blood"},{"key":"600_CR48","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/sj.emboj.7601570","volume":"26","author":"J Caumartin","year":"2007","unstructured":"Caumartin, J. et al. Trogocytosis-based generation of suppressive NK cells. EMBO J. 26, 1423\u20131433 (2007).","journal-title":"EMBO J."},{"key":"600_CR49","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.4049\/jimmunol.1000547","volume":"186","author":"KY HoWangYin","year":"2011","unstructured":"HoWangYin, K. Y. et al. Proper regrafting of Ig-like transcript 2 after trogocytosis allows a functional cell-cell transfer of sensitivity. J. Immunol. 186, 2210\u20132218 (2011).","journal-title":"J. Immunol."},{"key":"600_CR50","doi-asserted-by":"publisher","first-page":"13312","DOI":"10.1073\/pnas.1517724112","volume":"112","author":"T Tilburgs","year":"2015","unstructured":"Tilburgs, T., Evans, J. H., Crespo, \u00c2. & Strominger, J. L. The HLA-G cycle provides for both NK tolerance and immunity at the maternal-fetal interface. Proc. Natl Acad. Sci. USA 112, 13312\u201313317 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"600_CR51","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/hep.29529","volume":"67","author":"Y Ono","year":"2018","unstructured":"Ono, Y. et al. Graft-infiltrating PD-L1. Hepatology 67, 1499\u20131515 (2018).","journal-title":"Hepatology"},{"key":"600_CR52","first-page":"57","volume":"1","author":"TK Sigdel","year":"2014","unstructured":"Sigdel, T. K. et al. Perturbations in the urinary exosome in transplant rejection. Front. Med. 1, 57 (2014).","journal-title":"Front. Med."},{"key":"600_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204204","volume":"13","author":"JH Lim","year":"2018","unstructured":"Lim, J. H. et al. Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: a cross-sectional study. PLoS ONE 13, e0204204 (2018).","journal-title":"PLoS ONE"},{"key":"600_CR54","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1097\/TP.0000000000001572","volume":"101","author":"CM Tower","year":"2017","unstructured":"Tower, C. M. et al. Plasma C4d+ endothelial microvesicles increase in acute antibody-mediated rejection. Transplantation 101, 2235\u20132243 (2017).","journal-title":"Transplantation"},{"key":"600_CR55","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1097\/TP.0000000000001834","volume":"101","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. Plasma exosomes from HLA-sensitized kidney transplant recipients contain mRNA transcripts which predict development of antibody-mediated rejection. Transplantation 101, 2419\u20132428 (2017).","journal-title":"Transplantation"},{"key":"600_CR56","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1021\/acsnano.7b05083","volume":"11","author":"J Park","year":"2017","unstructured":"Park, J. et al. Integrated kidney exosome analysis for the detection of kidney transplant rejection. ACS Nano 11, 11041\u201311046 (2017).","journal-title":"ACS Nano"},{"key":"600_CR57","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","volume":"55","author":"LC Racusen","year":"1999","unstructured":"Racusen, L. C. et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55, 713\u2013723 (1999).","journal-title":"Kidney Int."},{"key":"600_CR58","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/01.TP.0000092494.75313.38","volume":"76","author":"H P\u00eache","year":"2003","unstructured":"P\u00eache, H., Heslan, M., Usal, C., Amigorena, S. & Cuturi, M. C. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76, 1503\u20131510 (2003).","journal-title":"Transplantation"},{"key":"600_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep32971","volume":"6","author":"B Ma","year":"2016","unstructured":"Ma, B. et al. Combining exosomes derived from immature DCs with donor antigen-specific Treg cells induces tolerance in a rat liver allograft model. Sci. Rep. 6, 32971 (2016).","journal-title":"Sci. Rep."},{"key":"600_CR60","doi-asserted-by":"crossref","unstructured":"Halloran, P. F., Einecke, G., Sikosana, M. L. N. & Madill-Thomsen, K. in Pharmacology of Immunosuppression. Handbook of Experimental Pharmacology Vol. 272 (ed. Eisen, H. J) 1\u201326 (Springer, 2021).","DOI":"10.1007\/164_2021_557"},{"key":"600_CR61","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1600-6143.2007.02129.x","volume":"8","author":"LG Hidalgo","year":"2008","unstructured":"Hidalgo, L. G. et al. The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. Am. J. Transpl. 8, 637\u2013646 (2008).","journal-title":"Am. J. Transpl."},{"key":"600_CR62","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/j.1600-6143.2005.00974.x","volume":"5","author":"G Einecke","year":"2005","unstructured":"Einecke, G. et al. Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection. Am. J. Transpl. 5, 1827\u20131836 (2005).","journal-title":"Am. J. Transpl."},{"key":"600_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12623","volume":"7","author":"Q Zhuang","year":"2016","unstructured":"Zhuang, Q. et al. Graft-infiltrating host dendritic cells play a key role in organ transplant rejection. Nat. Commun. 7, 12623 (2016).","journal-title":"Nat. Commun."},{"key":"600_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"F Tacke","year":"2007","unstructured":"Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185\u2013194 (2007).","journal-title":"J. Clin. Invest."},{"key":"600_CR65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1074-7613(03)00171-7","volume":"19","author":"NV Serbina","year":"2003","unstructured":"Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A. & Pamer, E. G. TNF\/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19, 59\u201370 (2003).","journal-title":"Immunity"},{"key":"600_CR66","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1073\/pnas.0900655106","volume":"106","author":"JR Aldridge","year":"2009","unstructured":"Aldridge, J. R. et al. TNF\/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl Acad. Sci. USA 106, 5306\u20135311 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"600_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000494","volume":"5","author":"C De Trez","year":"2009","unstructured":"De Trez, C. et al. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL\/6 resistant mice. PLoS Pathog. 5, e1000494 (2009).","journal-title":"PLoS Pathog."},{"key":"600_CR68","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/ki.1997.256","volume":"51","author":"MM D\u2019Elios","year":"1997","unstructured":"D\u2019Elios, M. M. et al. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int. 51, 1876\u20131884 (1997).","journal-title":"Kidney Int."},{"key":"600_CR69","first-page":"5763430","volume":"2019","author":"J Li","year":"2019","unstructured":"Li, J. et al. The evolving roles of macrophages in organ transplantation. J. Immunol. Res. 2019, 5763430 (2019).","journal-title":"J. Immunol. Res."},{"key":"600_CR70","first-page":"153","volume":"8","author":"TP van den Bosch","year":"2017","unstructured":"van den Bosch, T. P., Kannegieter, N. M., Hesselink, D. A., Baan, C. C. & Rowshani, A. T. Targeting the monocyte-macrophage lineage in solid organ transplantation. Front. Immunol. 8, 153 (2017).","journal-title":"Front. Immunol."},{"key":"600_CR71","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI200317477","volume":"111","author":"AB Adams","year":"2003","unstructured":"Adams, A. B. et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111, 1887\u20131895 (2003).","journal-title":"J. Clin. Invest."},{"key":"600_CR72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1600-065X.2003.00082.x","volume":"196","author":"AB Adams","year":"2003","unstructured":"Adams, A. B., Pearson, T. C. & Larsen, C. P. Heterologous immunity: an overlooked barrier to tolerance. Immunol. Rev. 196, 147\u2013160 (2003).","journal-title":"Immunol. Rev."},{"key":"600_CR73","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2009.11.007","volume":"31","author":"SC Jameson","year":"2009","unstructured":"Jameson, S. C. & Masopust, D. Diversity in T cell memory: an embarrassment of riches. Immunity 31, 859\u2013871 (2009).","journal-title":"Immunity"},{"key":"600_CR74","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.4049\/jimmunol.152.6.2675","volume":"152","author":"M Croft","year":"1994","unstructured":"Croft, M., Bradley, L. M. & Swain, S. L. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152, 2675\u20132685 (1994).","journal-title":"J. Immunol."},{"key":"600_CR75","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1172\/JCI66722","volume":"123","author":"JM Walch","year":"2013","unstructured":"Walch, J. M. et al. Cognate antigen directs CD8+ T cell migration to vascularized transplants. J. Clin. Invest. 123, 2663\u20132671 (2013).","journal-title":"J. Clin. Invest."},{"key":"600_CR76","first-page":"170","volume":"8","author":"G Benichou","year":"2017","unstructured":"Benichou, G., Gonzalez, B., Marino, J., Ayasoufi, K. & Valujskikh, A. Role of memory T cells in allograft rejection and tolerance. Front. Immunol. 8, 170 (2017).","journal-title":"Front. Immunol."},{"key":"600_CR77","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.4049\/jimmunol.172.9.5456","volume":"172","author":"Y Chen","year":"2004","unstructured":"Chen, Y., Heeger, P. S. & Valujskikh, A. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J. Immunol. 172, 5456\u20135466 (2004).","journal-title":"J. Immunol."},{"key":"600_CR78","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1034\/j.1600-6143.2002.20603.x","volume":"2","author":"A Valujskikh","year":"2002","unstructured":"Valujskikh, A., Pantenburg, B. & Heeger, P. S. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am. J. Transpl. 2, 501\u2013509 (2002).","journal-title":"Am. J. Transpl."},{"key":"600_CR79","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1128\/JVI.74.5.2210-2218.2000","volume":"74","author":"RM Welsh","year":"2000","unstructured":"Welsh, R. M. et al. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J. Virol. 74, 2210\u20132218 (2000).","journal-title":"J. Virol."},{"key":"600_CR80","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.4049\/jimmunol.169.8.4667","volume":"169","author":"Y Zhai","year":"2002","unstructured":"Zhai, Y., Meng, L., Gao, F., Busuttil, R. W. & Kupiec-Weglinski, J. W. Allograft rejection by primed\/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J. Immunol. 169, 4667\u20134673 (2002).","journal-title":"J. Immunol."},{"key":"600_CR81","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fimmu.2012.00036","volume":"3","author":"SM Krummey","year":"2012","unstructured":"Krummey, S. M. & Ford, M. L. Heterogeneity within T cell memory: implications for transplant tolerance. Front. Immunol. 3, 36 (2012).","journal-title":"Front. Immunol."},{"key":"600_CR82","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/MOT.0000000000000151","volume":"20","author":"SM Krummey","year":"2015","unstructured":"Krummey, S. M. & Ford, M. L. New insights into T-cell cosignaling in allograft rejection and survival. Curr. Opin. Organ. Transpl. 20, 43\u201348 (2015).","journal-title":"Curr. Opin. Organ. Transpl."},{"key":"600_CR83","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1172\/JCI95914","volume":"128","author":"DV Mathews","year":"2018","unstructured":"Mathews, D. V. et al. CD122 signaling in CD8+ memory T cells drives costimulation-independent rejection. J. Clin. Invest. 128, 4557\u20134572 (2018).","journal-title":"J. Clin. Invest."},{"key":"600_CR84","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/imr.12824","volume":"292","author":"CR Hartigan","year":"2019","unstructured":"Hartigan, C. R., Sun, H. & Ford, M. L. Memory T-cell exhaustion and tolerance in transplantation. Immunol. Rev. 292, 225\u2013242 (2019).","journal-title":"Immunol. Rev."},{"key":"600_CR85","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.bmt.1705185","volume":"36","author":"MY Shapira","year":"2005","unstructured":"Shapira, M. Y. et al. Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft-versus-host disease: a preliminary report. Bone Marrow Transpl. 36, 1097\u20131101 (2005).","journal-title":"Bone Marrow Transpl."},{"key":"600_CR86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/14653240802644669","volume":"11","author":"MY Shapira","year":"2009","unstructured":"Shapira, M. Y. et al. A new induction protocol for the control of steroid refractory\/dependent acute graft versus host disease with alefacept and tacrolimus. Cytotherapy 11, 61\u201367 (2009).","journal-title":"Cytotherapy"},{"key":"600_CR87","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/bmt.2008.324","volume":"43","author":"MY Shapira","year":"2009","unstructured":"Shapira, M. Y. et al. Alefacept treatment for refractory chronic extensive GVHD. Bone Marrow Transpl. 43, 339\u2013343 (2009).","journal-title":"Bone Marrow Transpl."},{"key":"600_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1600-6143.2010.03317.x","volume":"11","author":"DJ Lo","year":"2011","unstructured":"Lo, D. J. et al. Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. Am. J. Transpl. 11, 22\u201333 (2011).","journal-title":"Am. J. Transpl."},{"key":"600_CR89","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/nm.1993","volume":"15","author":"TA Weaver","year":"2009","unstructured":"Weaver, T. A. et al. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat. Med. 15, 746\u2013749 (2009).","journal-title":"Nat. Med."},{"key":"600_CR90","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2217\/imt.10.113","volume":"3","author":"WH Kitchens","year":"2011","unstructured":"Kitchens, W. H., Larsen, C. P. & Ford, M. L. Integrin antagonists for transplant immunosuppression: panacea or peril. Immunotherapy 3, 305\u2013307 (2011).","journal-title":"Immunotherapy"},{"key":"600_CR91","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-6143.2011.03762.x","volume":"12","author":"WH Kitchens","year":"2012","unstructured":"Kitchens, W. H. et al. Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8+ memory T cells. Am. J. Transpl. 12, 69\u201380 (2012).","journal-title":"Am. J. Transpl."},{"key":"600_CR92","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1600-6143.2011.03492.x","volume":"11","author":"K Setoguchi","year":"2011","unstructured":"Setoguchi, K. et al. LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Am. J. Transpl. 11, 923\u2013935 (2011).","journal-title":"Am. J. Transpl."},{"key":"600_CR93","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/ajt.15147","volume":"19","author":"S Iida","year":"2019","unstructured":"Iida, S. et al. Peritransplant VLA-4 blockade inhibits endogenous memory CD8 T cell infiltration into high-risk cardiac allografts and CTLA-4Ig resistant rejection. Am. J. Transpl. 19, 998\u20131010 (2019).","journal-title":"Am. J. Transpl."},{"key":"600_CR94","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/j.1600-6143.2010.03212.x","volume":"10","author":"NA Turgeon","year":"2010","unstructured":"Turgeon, N. A. et al. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am. J. Transpl. 10, 2082\u20132091 (2010).","journal-title":"Am. J. Transpl."},{"key":"600_CR95","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/j.1600-6143.2010.03073.x","volume":"10","author":"AM Posselt","year":"2010","unstructured":"Posselt, A. M. et al. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am. J. Transpl. 10, 1870\u20131880 (2010).","journal-title":"Am. J. Transpl."},{"key":"600_CR96","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1111\/j.1600-6143.2007.01845.x","volume":"7","author":"F Vincenti","year":"2007","unstructured":"Vincenti, F. et al. A phase I\/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am. J. Transpl. 7, 1770\u20131777 (2007).","journal-title":"Am. J. Transpl."},{"key":"600_CR97","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","volume":"10","author":"KR Carson","year":"2009","unstructured":"Carson, K. R. et al. Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the research on adverse drug events and reports (RADAR) project. Lancet Oncol. 10, 816\u2013824 (2009).","journal-title":"Lancet Oncol."},{"key":"600_CR98","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/9536","volume":"5","author":"AD Kirk","year":"1999","unstructured":"Kirk, A. D. et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5, 686\u2013693 (1999).","journal-title":"Nat. Med."},{"key":"600_CR99","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/381434a0","volume":"381","author":"CP Larsen","year":"1996","unstructured":"Larsen, C. P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434\u2013438 (1996).","journal-title":"Nature"},{"key":"600_CR100","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1111\/ajt.15835","volume":"20","author":"D Liu","year":"2020","unstructured":"Liu, D. & Ford, M. L. CD11b is a novel alternate receptor for CD154 during alloimmunity. Am. J. Transpl. 20, 2216\u20132225 (2020).","journal-title":"Am. J. Transpl."},{"key":"600_CR101","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.111.247684","volume":"109","author":"D Wolf","year":"2011","unstructured":"Wolf, D. et al. Binding of CD40L to Mac-1\u2019s I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis \u2014 but does not affect immunity and thrombosis in mice. Circ. Res. 109, 1269\u20131279 (2011).","journal-title":"Circ. Res."},{"key":"600_CR102","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fcvm.2017.00040","volume":"4","author":"NA Michel","year":"2017","unstructured":"Michel, N. A., Zirlik, A. & Wolf, D. CD40L and its receptors in atherothrombosis \u2014 an update. Front. Cardiovasc. Med. 4, 40 (2017).","journal-title":"Front. Cardiovasc. Med."},{"key":"600_CR103","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0952-7915(00)00130-8","volume":"12","author":"WW Hancock","year":"2000","unstructured":"Hancock, W. W., Gao, W., Faia, K. L. & Csizmadia, V. Chemokines and their receptors in allograft rejection. Curr. Opin. Immunol. 12, 511\u2013516 (2000).","journal-title":"Curr. Opin. Immunol."},{"key":"600_CR104","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/j.1600-6143.2008.02323.x","volume":"8","author":"PF Halloran","year":"2008","unstructured":"Halloran, P. F. & Fairchild, R. L. The puzzling role of CXCR3 and its ligands in organ allograft rejection. Am. J. Transpl. 8, 1578\u20131579 (2008).","journal-title":"Am. J. Transpl."},{"key":"600_CR105","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/TP.0b013e31820f0856","volume":"91","author":"MH Oberbarnscheidt","year":"2011","unstructured":"Oberbarnscheidt, M. H. et al. Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3. Transplantation 91, 827\u2013832 (2011).","journal-title":"Transplantation"},{"key":"600_CR106","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/00007890-200210150-00003","volume":"74","author":"SC Hoffmann","year":"2002","unstructured":"Hoffmann, S. C. et al. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 74, 916\u2013923 (2002).","journal-title":"Transplantation"},{"key":"600_CR107","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/imr.12146","volume":"258","author":"DN Mori","year":"2014","unstructured":"Mori, D. N., Kreisel, D., Fullerton, J. N., Gilroy, D. W. & Goldstein, D. R. Inflammatory triggers of acute rejection of organ allografts. Immunol. Rev. 258, 132\u2013144 (2014).","journal-title":"Immunol. Rev."},{"key":"600_CR108","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/ndt\/gft488","volume":"29","author":"C Ponticelli","year":"2014","unstructured":"Ponticelli, C. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol. Dial. Transpl. 29, 1134\u20131140 (2014).","journal-title":"Nephrol. Dial. Transpl."},{"key":"600_CR109","doi-asserted-by":"publisher","first-page":"a016246","DOI":"10.1101\/cshperspect.a016246","volume":"7","author":"S Pandey","year":"2014","unstructured":"Pandey, S., Kawai, T. & Akira, S. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb. Perspect. Biol. 7, a016246 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"600_CR110","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI200317573","volume":"111","author":"DR Goldstein","year":"2003","unstructured":"Goldstein, D. R., Tesar, B. M., Akira, S. & Lakkis, F. G. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111, 1571\u20131578 (2003).","journal-title":"J. Clin. Invest."},{"key":"600_CR111","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4049\/jimmunol.173.1.307","volume":"173","author":"D Messmer","year":"2004","unstructured":"Messmer, D. et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173, 307\u2013313 (2004).","journal-title":"J. Immunol."},{"key":"600_CR112","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/imm.12104","volume":"139","author":"S McNulty","year":"2013","unstructured":"McNulty, S. et al. Heat-shock proteins as dendritic cell-targeting vaccines \u2014 getting warmer. Immunology 139, 407\u2013415 (2013).","journal-title":"Immunology"},{"key":"600_CR113","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1111\/j.1600-6143.2006.01537.x","volume":"6","author":"BM Tesar","year":"2006","unstructured":"Tesar, B. M. et al. The role of hyaluronan degradation products as innate alloimmune agonists. Am. J. Transpl. 6, 2622\u20132635 (2006).","journal-title":"Am. J. Transpl."},{"key":"600_CR114","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/TP.0b013e31817b8dc5","volume":"86","author":"C Braudeau","year":"2008","unstructured":"Braudeau, C. et al. Contrasted blood and intragraft Toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 86, 130\u2013136 (2008).","journal-title":"Transplantation"},{"key":"600_CR115","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/iji.12446","volume":"46","author":"MH Sharbafi","year":"2019","unstructured":"Sharbafi, M. H. et al. TLR-2, TLR-4 and MyD88 genes expression in renal transplant acute and chronic rejections. Int. J. Immunogenet. 46, 427\u2013436 (2019).","journal-title":"Int. J. Immunogenet."},{"key":"600_CR116","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.transproceed.2007.02.102","volume":"39","author":"JF Deng","year":"2007","unstructured":"Deng, J. F. et al. The role of Toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. Transpl. Proc. 39, 3222\u20133224 (2007).","journal-title":"Transpl. Proc."},{"key":"600_CR117","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrneph.2016.41","volume":"12","author":"F Braza","year":"2016","unstructured":"Braza, F., Brouard, S., Chadban, S. & Goldstein, D. R. Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat. Rev. Nephrol. 12, 281\u2013290 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"600_CR118","doi-asserted-by":"publisher","first-page":"104088","DOI":"10.1016\/j.cellimm.2020.104088","volume":"351","author":"HS Kulkarni","year":"2020","unstructured":"Kulkarni, H. S., Scozzi, D. & Gelman, A. E. Recent advances into the role of pattern recognition receptors in transplantation. Cell Immunol. 351, 104088 (2020).","journal-title":"Cell Immunol."},{"key":"600_CR119","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/ClinicalTrials.gov\/show\/NCT01794663 (2017)."},{"key":"600_CR120","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/ClinicalTrials.gov\/show\/NCT01808469 (2014)."},{"key":"600_CR121","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41581-018-0071-x","volume":"14","author":"AR Biglarnia","year":"2018","unstructured":"Biglarnia, A. R., Huber-Lang, M., Mohlin, C., Ekdahl, K. N. & Nilsson, B. The multifaceted role of complement in kidney transplantation. Nat. Rev. Nephrol. 14, 767\u2013781 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"600_CR122","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.2215\/CJN.06230614","volume":"10","author":"DR Mathern","year":"2015","unstructured":"Mathern, D. R. & Heeger, P. S. Molecules great and small: the complement system. Clin. J. Am. Soc. Nephrol. 10, 1636\u20131650 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"600_CR123","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood-2008-04-151068","volume":"112","author":"PN Lalli","year":"2008","unstructured":"Lalli, P. N. et al. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 112, 1759\u20131766 (2008).","journal-title":"Blood"},{"key":"600_CR124","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","volume":"28","author":"MG Strainic","year":"2008","unstructured":"Strainic, M. G. et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28, 425\u2013435 (2008).","journal-title":"Immunity"},{"key":"600_CR125","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4049\/jimmunol.1700339","volume":"199","author":"JH Sheen","year":"2017","unstructured":"Sheen, J. H. et al. TLR-induced murine dendritic cell (DC) activation requires DC-intrinsic complement. J. Immunol. 199, 278\u2013291 (2017).","journal-title":"J. Immunol."},{"key":"600_CR126","doi-asserted-by":"publisher","first-page":"aad1210","DOI":"10.1126\/science.aad1210","volume":"352","author":"G Arbore","year":"2016","unstructured":"Arbore, G. et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells. Science 352, aad1210 (2016).","journal-title":"Science"},{"key":"600_CR127","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/ajt.15222","volume":"19","author":"DR Mathern","year":"2019","unstructured":"Mathern, D. R., K Horwitz, J. & Heeger, P. S. Absence of recipient C3aR1 signaling limits expansion and differentiation of alloreactive CD8+ T cell immunity and prolongs murine cardiac allograft survival. Am. J. Transpl. 19, 1628\u20131640 (2019).","journal-title":"Am. J. Transpl."},{"key":"600_CR128","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1084\/jem.20121525","volume":"210","author":"WH Kwan","year":"2013","unstructured":"Kwan, W. H., van der Touw, W., Paz-Artal, E., Li, M. O. & Heeger, P. S. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J. Exp. Med. 210, 257\u2013268 (2013).","journal-title":"J. Exp. Med."},{"key":"600_CR129","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ni.2499","volume":"14","author":"MG Strainic","year":"2013","unstructured":"Strainic, M. G., Shevach, E. M., An, F., Lin, F. & Medof, M. E. Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-\u03b21 signaling and induction of Foxp3+ regulatory T cells. Nat. Immunol. 14, 162\u2013171 (2013).","journal-title":"Nat. Immunol."},{"key":"600_CR130","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.4049\/jimmunol.1300847","volume":"190","author":"W van der Touw","year":"2013","unstructured":"van der Touw, W. et al. Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J. Immunol. 190, 5921\u20135925 (2013).","journal-title":"J. Immunol."},{"key":"600_CR131","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/383263a0","volume":"383","author":"M Ono","year":"1996","unstructured":"Ono, M., Bolland, S., Tempst, P. & Ravetch, J. V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc\u03b3RIIB. Nature 383, 263\u2013266 (1996).","journal-title":"Nature"},{"key":"600_CR132","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn, F. & Ravetch, J. V. Fc\u03b3 receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34\u201347 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"600_CR133","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2010.06.014","volume":"33","author":"TC Wirth","year":"2010","unstructured":"Wirth, T. C. et al. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8+ T cell differentiation. Immunity 33, 128\u2013140 (2010).","journal-title":"Immunity"},{"key":"600_CR134","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4049\/jimmunol.1302232","volume":"192","author":"GR Starbeck-Miller","year":"2014","unstructured":"Starbeck-Miller, G. R., Badovinac, V. P., Barber, D. L. & Harty, J. T. Cutting edge: expression of Fc\u03b3RIIB tempers memory CD8 T cell function in vivo. J. Immunol. 192, 35\u201339 (2014).","journal-title":"J. Immunol."},{"key":"600_CR135","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","volume":"571","author":"F Alfei","year":"2019","unstructured":"Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265\u2013269 (2019).","journal-title":"Nature"},{"key":"600_CR136","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.immuni.2019.12.006","volume":"52","author":"AB Morris","year":"2020","unstructured":"Morris, A. B. et al. Signaling through the inhibitory Fc receptor Fc\u03b3RIIB induces CD8. Immunity 52, 136\u2013150.e6 (2020).","journal-title":"Immunity"},{"key":"600_CR137","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1002\/eji.200838338","volume":"38","author":"H Liu","year":"2008","unstructured":"Liu, H. et al. The FGL2-Fc\u03b3RIIB pathway: a novel mechanism leading to immunosuppression. Eur. J. Immunol. 38, 3114\u20133126 (2008).","journal-title":"Eur. J. Immunol."},{"key":"600_CR138","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1681\/ASN.2014121234","volume":"26","author":"DE Hricik","year":"2015","unstructured":"Hricik, D. E. et al. Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients. J. Am. Soc. Nephrol. 26, 3114\u20133122 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"600_CR139","first-page":"325","volume":"35","author":"J Hu","year":"2016","unstructured":"Hu, J. et al. The duality of Fgl2-secreted immune checkpoint regulator versus membrane-associated procoagulant: therapeutic potential and implications. Int. Rev. Immunol. 35, 325\u2013339 (2016).","journal-title":"Int. Rev. Immunol."},{"key":"600_CR140","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","volume":"40","author":"N Joller","year":"2014","unstructured":"Joller, N. et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 40, 569\u2013581 (2014).","journal-title":"Immunity"},{"key":"600_CR141","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","volume":"115","author":"AL Amir","year":"2010","unstructured":"Amir, A. L. et al. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115, 3146\u20133157 (2010).","journal-title":"Blood"},{"key":"600_CR142","doi-asserted-by":"publisher","first-page":"86ra51","DOI":"10.1126\/scitranslmed.3002093","volume":"3","author":"O Nadazdin","year":"2011","unstructured":"Nadazdin, O. et al. Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci. Transl Med. 3, 86ra51 (2011).","journal-title":"Sci. Transl Med."},{"key":"600_CR143","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.trim.2018.06.003","volume":"50","author":"AM Bozeman","year":"2018","unstructured":"Bozeman, A. M., Laurie, S. J., Haridas, D., Wagener, M. E. & Ford, M. L. Transplantation preferentially induces a KLRG-1lo CD127hi differentiation program in antigen-specific CD8+ T cells. Transpl. Immunol. 50, 34\u201342 (2018).","journal-title":"Transpl. Immunol."},{"key":"600_CR144","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1084\/jem.182.6.1703","volume":"182","author":"SR Burrows","year":"1995","unstructured":"Burrows, S. R. et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 182, 1703\u20131715 (1995).","journal-title":"J. Exp. Med."},{"key":"600_CR145","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-immunol-072710-081639","volume":"29","author":"E Barton","year":"2011","unstructured":"Barton, E., Mandal, P. & Speck, S. H. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu. Rev. Immunol. 29, 351\u2013397 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"600_CR146","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","volume":"5","author":"CP Larsen","year":"2005","unstructured":"Larsen, C. P. et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am. J. Transpl. 5, 443\u2013453 (2005).","journal-title":"Am. J. Transpl."},{"key":"600_CR147","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.4049\/jimmunol.1003015","volume":"186","author":"TL Floyd","year":"2011","unstructured":"Floyd, T. L. et al. Limiting the amount and duration of antigen exposure during priming increases memory T cell requirement for costimulation during recall. J. Immunol. 186, 2033\u20132041 (2011).","journal-title":"J. Immunol."},{"key":"600_CR148","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/ajt.12719","volume":"14","author":"O Traitanon","year":"2014","unstructured":"Traitanon, O. et al. IL-15 induces alloreactive CD28\u2212 memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation. Am. J. Transpl. 14, 1277\u20131289 (2014).","journal-title":"Am. J. Transpl."},{"key":"600_CR149","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ekir.2022.01.1042","volume":"7","author":"A Asderakis","year":"2022","unstructured":"Asderakis, A. et al. Thymoglobulin versus alemtuzumab versus basiliximab kidney transplantation from donors after circulatory death. Kidney Int. Rep. 7, 732\u2013740 (2022).","journal-title":"Kidney Int. Rep."},{"key":"600_CR150","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1172\/JCI135060","volume":"130","author":"CB Xie","year":"2020","unstructured":"Xie, C. B. et al. Complement-activated interferon-gamma-primed human endothelium transpresents interleukin-15 to CD8+ T cells. J. Clin. Invest. 130, 3437\u20133452 (2020).","journal-title":"J. Clin. Invest."},{"key":"600_CR151","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1600-6143.2011.03473.x","volume":"11","author":"IR Ferrer","year":"2011","unstructured":"Ferrer, I. R., Araki, K. & Ford, M. L. Paradoxical aspects of rapamycin immunobiology in transplantation. Am. J. Transpl. 11, 654\u2013659 (2011).","journal-title":"Am. J. Transpl."},{"key":"600_CR152","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1600-6143.2010.03407.x","volume":"11","author":"AP Turner","year":"2011","unstructured":"Turner, A. P. et al. Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am. J. Transpl. 11, 613\u2013618 (2011).","journal-title":"Am. J. Transpl."},{"key":"600_CR153","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08155","volume":"460","author":"K Araki","year":"2009","unstructured":"Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"600_CR154","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.4049\/jimmunol.1001176","volume":"185","author":"IR Ferrer","year":"2010","unstructured":"Ferrer, I. R. et al. Cutting edge: rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J. Immunol. 185, 2004\u20132008 (2010).","journal-title":"J. Immunol."},{"key":"600_CR155","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.1130563","volume":"313","author":"N F\u00f6ger","year":"2006","unstructured":"F\u00f6ger, N., Rangell, L., Danilenko, D. M. & Chan, A. C. Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis. Science 313, 839\u2013842 (2006).","journal-title":"Science"},{"key":"600_CR156","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/ni1570","volume":"9","author":"P Mueller","year":"2008","unstructured":"Mueller, P. et al. Regulation of T cell survival through coronin-1-mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering. Nat. Immunol. 9, 424\u2013431 (2008).","journal-title":"Nat. Immunol."},{"key":"600_CR157","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/ni.1662","volume":"9","author":"LR Shiow","year":"2008","unstructured":"Shiow, L. R. et al. The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency. Nat. Immunol. 9, 1307\u20131315 (2008).","journal-title":"Nat. Immunol."},{"key":"600_CR158","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.immuni.2018.12.011","volume":"50","author":"R Jayachandran","year":"2019","unstructured":"Jayachandran, R. et al. Disruption of coronin 1 signaling in T cells promotes allograft tolerance while maintaining anti-pathogen immunity. Immunity 50, 152\u2013165.e8 (2019).","journal-title":"Immunity"},{"key":"600_CR159","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1126\/science.184.4132.19","volume":"184","author":"HR Bourne","year":"1974","unstructured":"Bourne, H. R. et al. Modulation of inflammation and immunity by cyclic AMP. Science 184, 19\u201328 (1974).","journal-title":"Science"},{"key":"600_CR160","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.20062129","volume":"204","author":"T Bopp","year":"2007","unstructured":"Bopp, T. et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303\u20131310 (2007).","journal-title":"J. Exp. Med."},{"key":"600_CR161","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cellsig.2010.11.018","volume":"23","author":"R Mosenden","year":"2011","unstructured":"Mosenden, R. & Task\u00e9n, K. Cyclic AMP-mediated immune regulation \u2014 overview of mechanisms of action in T cells. Cell. Signal. 23, 1009\u20131016 (2011).","journal-title":"Cell. Signal."},{"key":"600_CR162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.immuni.2018.12.030","volume":"50","author":"ML Ford","year":"2019","unstructured":"Ford, M. L. Coronin-1, King of Alloimmunity. Immunity 50, 3\u20135 (2019).","journal-title":"Immunity"},{"key":"600_CR163","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jaci.2013.01.042","volume":"131","author":"D Moshous","year":"2013","unstructured":"Moshous, D. et al. Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation. J. Allergy Clin. Immunol. 131, 1594\u20131603 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"600_CR164","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","volume":"47","author":"K Man","year":"2017","unstructured":"Man, K. et al. Transcription factor IRF4 promotes CD8+ T cell exhaustion and limits the development of memory-like T cells during chronic infection. Immunity 47, 1129\u20131141.e5 (2017).","journal-title":"Immunity"},{"key":"600_CR165","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.immuni.2017.11.003","volume":"47","author":"J Wu","year":"2017","unstructured":"Wu, J. et al. Ablation of transcription factor IRF4 promotes transplant acceptance by driving allogenic CD4+ T cell dysfunction. Immunity 47, 1114\u20131128.e6 (2017).","journal-title":"Immunity"},{"key":"600_CR166","doi-asserted-by":"publisher","first-page":"105758","DOI":"10.1016\/j.intimp.2019.105758","volume":"75","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Bortezomib ameliorates acute allograft rejection after renal transplant by inhibiting Tfh cell proliferation and differentiation via miR-15b\/IRF4 axis. Int. Immunopharmacol. 75, 105758 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"600_CR167","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.153.12.5402","volume":"153","author":"DE Epperson","year":"1994","unstructured":"Epperson, D. E. & Pober, J. S. Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. J. Immunol. 153, 5402\u20135412 (1994).","journal-title":"J. Immunol."},{"key":"600_CR168","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature17655","volume":"532","author":"LK Beura","year":"2016","unstructured":"Beura, L. K. et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532, 512\u2013516 (2016).","journal-title":"Nature"},{"key":"600_CR169","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MOT.0000000000000375","volume":"22","author":"PD Winterberg","year":"2017","unstructured":"Winterberg, P. D. & Ford, M. L. The effect of chronic kidney disease on T cell alloimmunity. Curr. Opin. Organ. Transpl. 22, 22\u201328 (2017).","journal-title":"Curr. Opin. Organ. Transpl."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00600-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T20:55:01Z","timestamp":1676235301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00600-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":169,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1038\/s41581-022-00600-0","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"23 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L.F. has received speaking honoraria from Veloxis Pharmaceuticals and Sanofi. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}